GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Guizhou Xinbang Pharmaceutical Co Ltd (SZSE:002390) » Definitions » 14-Day RSI

Guizhou Xinbang Pharmaceutical Co (SZSE:002390) 14-Day RSI : 65.73 (As of Dec. 15, 2024)


View and export this data going back to 2010. Start your Free Trial

What is Guizhou Xinbang Pharmaceutical Co 14-Day RSI?

The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.

As of today (2024-12-15), Guizhou Xinbang Pharmaceutical Co's 14-Day RSI is 65.73.

The industry rank for Guizhou Xinbang Pharmaceutical Co's 14-Day RSI or its related term are showing as below:

SZSE:002390's 14-Day RSI is ranked worse than
92.6% of 1095 companies
in the Drug Manufacturers industry
Industry Median: 48.1 vs SZSE:002390: 65.73

Competitive Comparison of Guizhou Xinbang Pharmaceutical Co's 14-Day RSI

For the Drug Manufacturers - Specialty & Generic subindustry, Guizhou Xinbang Pharmaceutical Co's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Guizhou Xinbang Pharmaceutical Co's 14-Day RSI Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Guizhou Xinbang Pharmaceutical Co's 14-Day RSI distribution charts can be found below:

* The bar in red indicates where Guizhou Xinbang Pharmaceutical Co's 14-Day RSI falls into.



Guizhou Xinbang Pharmaceutical Co  (SZSE:002390) 14-Day RSI Calculation

The formula for calculating RSI is:

RSI=100[ 100 / ( 1 + Average Gain / Average Loss )]

* Note that the formula uses a positive value for the average loss.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Guizhou Xinbang Pharmaceutical Co  (SZSE:002390) 14-Day RSI Explanation

The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.

Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.

RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.


Guizhou Xinbang Pharmaceutical Co 14-Day RSI Related Terms

Thank you for viewing the detailed overview of Guizhou Xinbang Pharmaceutical Co's 14-Day RSI provided by GuruFocus.com. Please click on the following links to see related term pages.


Guizhou Xinbang Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
6th Floor, Kekai 1st Court, Intersection of Aerospace Avenue and Xintian Avenue, Wudang District, Guiyang, CHN
Guizhou Xinbang Pharmaceutical Co Ltd is a China-based pharmaceutical company. The company is engaged in providing medical services and pharmaceutical distribution. The scope of business also covers the cultivation of Chinese herbal medicines, production of Chinese herbal medicines and Chinese patent medicines, research and development, production and sales of biological drugs, and other fields.
Executives
An Ji Director
Gao Wen Lin Executives
Lu Ya Fang Executives
Xu Qi Directors, executives
An Huai Lve Director
Ma Cheng Director
Zhang Jie Qing Directors, executives
Kong Ling Zhong Directors, executives
Liu Xiao Yang Executives
Xiao Ya Yun Executives
Yang Pei Executives
Zhang Guan Fu Director
Chen Chuan Directors, executives
He Wen Jun Supervisors
Lv Yu Tao Director

Guizhou Xinbang Pharmaceutical Co Headlines

No Headlines